Search Results - "Schernthaner, G.‐H."

Refine Results
  1. 1

    Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site by Hadzijusufovic, E, Albrecht-Schgoer, K, Huber, K, Hoermann, G, Grebien, F, Eisenwort, G, Schgoer, W, Herndlhofer, S, Kaun, C, Theurl, M, Sperr, W R, Rix, U, Sadovnik, I, Jilma, B, Schernthaner, G H, Wojta, J, Wolf, D, Superti-Furga, G, Kirchmair, R, Valent, P

    Published in Leukemia (01-11-2017)
    “…The BCR/ABL1 inhibitor Nilotinib is increasingly used to treat patients with chronic myeloid leukemia (CML). Although otherwise well-tolerated, Nilotinib has…”
    Get full text
    Journal Article
  2. 2

    Expression of the target receptor CD33 in CD34+/CD38−/CD123+ AML stem cells by Hauswirth, A.W., Florian, S., Printz, D., Sotlar, K., Krauth, M.-T., Fritsch, G., Schernthaner, G.-H., Wacheck, V., Selzer, E., Sperr, W.R., Valent, P.

    Published in European journal of clinical investigation (01-01-2007)
    “…Background  CD33 (Siglec‐3) is becoming increasingly important as a target of antibody‐mediated therapy in acute myeloid leukaemia (AML). In normal…”
    Get full text
    Journal Article
  3. 3

    Thrombin generation in morbid obesity: significant reduction after weight loss by AY, L., KOPP, H.‐P., BRIX, J.‐M., AY, C., QUEHENBERGER, P., SCHERNTHANER, G.‐H., PABINGER, I., SCHERNTHANER, G.

    Published in Journal of thrombosis and haemostasis (01-04-2010)
    “…Background: Patients with morbid obesity (MO; body mass index > 40 kg m−2) suffer from an increased risk of cardiovascular disease, stroke, venous…”
    Get full text
    Journal Article
  4. 4

    Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess by Poredoš, P, Schernthaner, G H, Blinc, A, Mikhailidis, D P, Jensterle, M, Anagnostis, P, Antignani, P L, Studen, K Bajuk, Šabović, M, Ježovnik, M K

    Published in Current vascular pharmacology (01-01-2024)
    “…Cushing syndrome (CS), characterised by endogenous or exogenous glucocorticoid hormone excess, is associated with several systemic complications, including…”
    Get more information
    Journal Article
  5. 5

    Glucose-lowering therapy in type 2 diabetes: New hope after the EMPA-REG outcome trial by Schernthaner, G., Schernthaner, G.-H.

    Published in Herz (01-05-2016)
    “…Prevention of cardiovascular morbidity and mortality remains the key factor in the treatment of type 2 diabetes (T2DM). In the early phase of T2DM,…”
    Get full text
    Journal Article
  6. 6

    The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity by Brix, J M, Höllerl, F, Kopp, H-P, Schernthaner, G H, Schernthaner, G

    Published in International Journal of Obesity (01-11-2012)
    “…Objective: The increased cardiovascular (CV) disease risk in patients with morbid obesity (MO) cannot be fully explained by traditional CV risk factors…”
    Get full text
    Journal Article
  7. 7

    Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes by Krzyzanowska, K, Zemany, L, Krugluger, W, Schernthaner, G. H, Mittermayer, F, Schnack, C, Rahman, R, Brix, J, Kahn, B. B, Schernthaner, G

    Published in Diabetologia (01-07-2008)
    “…Aims/hypothesis Pregnancy is characterised by temporarily increased insulin resistance. Gestational diabetes occurs when pancreatic beta cell function is…”
    Get full text
    Journal Article
  8. 8

    Variable expression of activation-linked surface antigens on human mast cells in health and disease by Valent, P., Schernthaner, G.-H., Sperr, W. R., Fritsch, G., Agis, H., Willheim, M., Bühring, H.-J., Orfao, A., Escribano, L.

    Published in Immunological reviews (01-02-2001)
    “…Mast cells (MC) are multipotent effector cells of the immune system. They contain an array of biologically active mediator substances in their granules. MC…”
    Get full text
    Journal Article
  9. 9

    Microvascular autoregulation in children and adolescents with type 1 diabetes mellitus by Schlager, O., Hammer, A., Willfort-Ehringer, A., Fritsch, M., Rami-Merhar, B., Schober, E., Nagl, K., Giurgea, A., Margeta, C., Zehetmayer, S., Schernthaner, G. H., Koppensteiner, R., Gschwandtner, M. E.

    Published in Diabetologia (01-06-2012)
    “…Aims/hypothesis Deterioration of microvascular function may have an early onset in individuals with type 1 diabetes mellitus. We hypothesised that…”
    Get full text
    Journal Article
  10. 10

    Detection of differentiation‐ and activation‐linked cell surface antigens on cultured mast cell progenitors by Schernthaner, G.‐H., Hauswirth, A. W., Baghestanian, M., Agis, H., Ghannadan, M., Worda, C., Krauth, M.‐T., Printz, D., Fritsch, G., Sperr, W. R., Valent, P.

    Published in Allergy (Copenhagen) (01-10-2005)
    “…Background:  Mast cells (MC) are multifunctional effector cells of the immune system. They derive from uncommitted CD34+ hemopoietic progenitor cells (HPC)…”
    Get full text
    Journal Article
  11. 11

    Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery by Schernthaner, G.-H., Kopp, H.-P., Krzyzanowska, K., Kriwanek, S., Koppensteiner, R., Schernthaner, G.

    Published in European journal of clinical investigation (01-06-2006)
    “…Background  Morbid obesity is associated with increased cardiovascular morbidity and mortality. Recent studies suggest that soluble CD40 Ligand (sCD40L) may…”
    Get full text
    Journal Article
  12. 12

    Chronic complications of venous thromboembolism by Winter, M.‐P., Schernthaner, G. H., Lang, I. M.

    Published in Journal of thrombosis and haemostasis (01-08-2017)
    “…Summary Venous thromboembolism (VTE) is a common disease (~700 per 100 000) that is associated with significant risk of recurrence, chronic complications, and…”
    Get full text
    Journal Article
  13. 13

    No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease by Schernthaner, G.-H., Plank, C., Minar, E., Bieglmayer, C., Koppensteiner, R., Schernthaner, G.

    Published in European journal of clinical investigation (01-05-2006)
    “…Background  Although peripheral arterial occlusive disease (PAOD) is significantly associated with elevated homocysteine levels, the clinical relevance of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Effects of various statins on cytokine‐dependent growth and IgE‐dependent release of histamine in human mast cells by Krauth, M. T., Majlesi, Y., Sonneck, K., Samorapoompichit, P., Ghannadan, M., Hauswirth, A. W., Baghestanian, M., Schernthaner, G. H., Worda, C., Müller, M. R., Sperr, W. R., Valent, P.

    Published in Allergy (Copenhagen) (01-03-2006)
    “…Background:  Statins are inhibitors of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase, a key enzyme in mevalonic acid (MVA)‐dependent signaling. Recent…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis by Sperr, Wolfgang R, Escribano, Luis, Jordan, John-Hendrik, Schernthaner, Gerit-Holger, Kundi, Michael, Horny, Hans-Peter, Valent, Peter

    Published in Leukemia research (01-07-2001)
    “…In the present study, cytological properties of bone marrow mast cells (MC) were analyzed and correlated with clinical parameters in 69 patients with systemic…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy by Samorapoompichit, P, Schernthaner, G-H, Worda, C, Wimazal, F, Krauth, M-T, Sperr, W R, Valent, P

    Published in Histopathology (01-02-2006)
    “…Aims : To analyse and characterize the ultrastructural morphology of normal tissue mast cells (MC) and neoplastic bone marrow MC. Methods : We have examined…”
    Get full text
    Journal Article
  19. 19

    Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis by Escribano, Luis, Dı́az-Agustı́n, Beatriz, Bellas, Carmen, Navalón, Raquel, Nuñez, Rosa, Sperr, Wolfgang R, Schernthaner, Gerit-Holger, Valent, Peter, Orfao, Alberto

    Published in Leukemia research (01-07-2001)
    “…The diagnosis of bone marrow (BM) involvement in mastocytosis has mainly been based on conventional histology. Nevertheless, in recent years, three major…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Secreted Frizzled-Related Protein 4 (SFRP4) is Elevated in Patients with Diabetes Mellitus by Brix, J M, Krzizek, E C, Hoebaus, C, Ludvik, B, Schernthaner, G, Schernthaner, G H

    Published in Hormone and metabolic research (01-05-2016)
    “…Recently, SFRP4 was identified as a molecular link between islet inflammation and defective insulin secretion. Gene co-expression analysis detected a molecule…”
    Get more information
    Journal Article